Rubicon Research Limited
Nomura trimmed its stake in Rubicon Research from 1.35% to 1.10% by selling 4,12,160 shares. Following the transaction, its holding stands at 18,27,735 shares.
A pharmaceutical company engaged in the development, manufacturing, and commercialization of differentiated drug formulations across multiple therapeutic areas. Incorporated in 1999, the company specializes in creating specialized formulations that address specific medical needs in the Indian healthcare market. Its integrated operations span research and development, manufacturing of quality pharmaceuticals, and distribution. The company distinguishes itself through its focus on bringing innovative, differentiated solutions to patients and healthcare providers.
Japan's largest investment bank. India FPI activity covers proprietary, market-making, client flows and mandates such as the EPF Malaysia India allocation.